![]() |
|
|
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
Human MTA1 | |
Goat | |
Human (tested or 100% immunogen sequence identity) | |
Polyclonal | |
Unconjugated | |
Immunoaffinity purified | |
Unmodified |
MTA1 antibody was raised against synthetic peptide C-PGDVFYMPKE from an internal region (near the C-terminus) of human MTA1 (NP_004680.1). Percent identity by BLAST analysis: Penicillium, Trichomonas, Coccidioides (80%). | ||
|
||
Internal | ||
Human MTA1. | ||
Peptide ELISA: antibody detection limit dilution 1:16000. Western blot: Approx 75 kDa band observed in Human Placenta lysates (calculated MW of 80.8 kDa according to NP_004680.1). Recommended concentration: 0.03-0.1 ug/ml. |
Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide | |
Store at -20°C. Avoid freeze-thaw cycles. | |
For research use only. |
MTA1 Antibody, Metastasis associated 1 Antibody
Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator. As a part of the histone-deacetylase multiprotein complex (NuRD), regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA. In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A.
|
|
|
|